Ultragenyx Pharmaceutical Inc. Collaboration Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 11 to Collaboration and License Agreement, effective as of December 17, 2021 between Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2022
Amendment No. 13 to Collaboration and License Agreement, effective as of May 16, 2023, between Ultragenyx Pharmaceutical Inc. and Kyowa Kirin, Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
2023
Amendment No. 12 to Collaboration and License Agreement, effective as of September 29, 2022, between Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2022
Amendment 10 to Collaboration and License Agreement effective as of April 1, 2020 between Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2020
Amendment No. 9 to Collaboration and License Agreement, effective December 23, 2019, between Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2020
Amended and Restated Collaboration and License Agreement, dated June 3, 2019, between Ultragenyx Pharmaceutical Inc. and Bayer Healthcare LLC
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
PA
2019
Amendment No. 8 to Collaboration and License Agreement, effective as of July 4, 2019, between Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd. (formerly, Kyowa Hakko Kirin...
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2019
Amendment No. 7 to Collaboration and License Agreement, entered into as of December 5, 2018, between Ultragenyx Pharmaceutical Inc. and Kyowa Hakko Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2019
Amendment No. 6 to Collaboration and License Agreement, effective as of February 1, 2019, between Ultragenyx Pharmaceutical Inc. and Kyowa Hakko Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2019
Amendment No. 5 to Collaboration and License Agreement, effective as of April 30, 2018, between Ultragenyx Pharmaceutical Inc. and Kyowa Hakko Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2018
Amendment No. 4 to Collaboration and License Agreement, effective as of January 29, 2018, between Ultragenyx Pharmaceutical Inc. and Kyowa Hakko Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2018
Amendment No. 3 to Collaboration and License Agreement, effective September 29, 2017, between Ultragenyx Pharmaceutical Inc. and Kyowa Hakko Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2018
Amendment No. 2 to Collaboration and License Agreement, effective as of November 28, 2016, between Ultragenyx Pharmaceutical Inc. and Kyowa Hakko Kirin Co., Ltd
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2018
AMENDMENT NO. 1 TO COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
2015
COLLABORATION AND LICENSE AGREEMENT BETWEEN NOBELPHARMA CO.,LTD. AND ULTRAGENYX PHARMACEUTICALS, INC
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
NY
2013
COLLABORATION AND LICENSE AGREEMENT by and between KYOWAHAKKO KIRIN CO., LTD. and ULTRAGENYX PHARMACEUTICAL INC. Dated August 29, 2013
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2013
COLLABORATION AND LICENSE AGREEMENT BETWEEN NOBELPHARMA CO.,LTD. AND ULTRAGENYX PHARMACEUTICALS, INC
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
NY
2013
COLLABORATION AND LICENSE AGREEMENT by and between KYOWAHAKKO KIRIN CO., LTD. and ULTRAGENYX PHARMACEUTICAL INC. Dated August 29, 2013
Collaboration Agreements
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2013